Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11,944 GBX | -0.83% |
|
-1.17% | +12.68% |
Jul. 05 | AstraZeneca's Tagrisso Approved by EU as First-Line Treatment for Non-Small Cell Lung Cancer | MT |
Jul. 05 | AstraZeneca: cancer treatment approved by the EU | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.68% | 240B | |
+59.97% | 827B | |
+38.38% | 634B | |
-6.18% | 350B | |
+15.61% | 319B | |
+8.44% | 294B | |
+14.40% | 221B | |
+0.04% | 219B | |
+9.68% | 167B | |
-3.72% | 158B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca, Mankind Pharma Tie Up for Exclusive Distribution of Asthma Drug Symbicort in India